Basics Kymera Therapeutics, Inc. IPO Date: August 21, 2020 Sector: Healthcare Industry: Biotech Market Cap: $4.79B Activated in VL: True Average Daily Range Avg Daily Range: $1.20 | 3.16% Avg Daily Range (30 D): $1.37 | 2.23% Avg Daily Range (90 D): $1.26 | 2.37% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): .6M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 2,343 Avg Inst. Trade: $2.48M Avg Inst. Trade (30 D): $3.48M Avg Inst. Trade (90 D): $3.33M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.35M Avg Closing Trade (30 D): $5.41M Avg Closing Trade (90 D): $5.47M Avg Closing Volume: 92.7K     News Nov 25, 2025 @ 12:00 PM Kymera Therapeutics Announces First Patient Dosed ... Source: Kymera Therapeutics Oct 28, 2025 @ 11:00 AM Kymera Therapeutics to Report Third Quarter 2025 F... Source: Justine Koenigsberg Sep 17, 2025 @ 11:00 AM Kymera Therapeutics Announces Late-Breaking Oral P... Source: Kymera Therapeutics Sep 3, 2025 @ 11:00 AM Kymera Therapeutics Appoints Brian Adams as Chief ... Source: Brian Adams Aug 13, 2025 @ 12:00 PM Hatteras Venture Partners Raises Over $200 Million... Source: Clay Thorp And John Crumpler Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.6 $-.94 $-.95 Diluted EPS $-3.6 $-.94 $-.95 Revenue $ 43.74M $ 2.76M $ 11.48M Gross Profit $ M $ M $ M Net Income / Loss $ -295.12M $ -82.18M $ -76.61M Operating Income / Loss $ -332.26M $ -92.52M $ -84.56M Cost of Revenue $ 43.74M $ 2.76M $ 11.48M Net Cash Flow $ 2.24M $ -222.9M $ 245.86M PE Ratio